Top 10 Life Science VC Funds in Austria

Last updated: Apr 2024 A list of 10 VC funds that invest in Life science startups based in Austria. We rank investors based on the number of investments they made in Life science companies from Austria. We update this investor list every month.

Top 10 Life Science VC Funds in Austria

Investor	Life Science Austria investments
xista science ventures	3
APEX Ventures	2
Longevitytech.fund	2
R42 Group	2
Nina Capital	2
HCVC	1
Polaris Partners	1
tecnet equity	1
OrbiMed	1
FastVentures	1

Find investors that fund startups like yours. Automatically.

Our algorithm will find investors that invest in your industry, stage, and geography.

Investor list

We invest in deep tech startups and academic spin-offs with a strong innovation based on science, engineering and technology. We invest as lead investor in pre-seed and seed stages and have the ability to follow on in later rounds. We understand the needs of science and tech based startups and offer tailored support for entrepreneurs. We areembedded in the venture capital scene, yet understand the language of science and the world of research. Thanks to our diverse team, our expertise and experience in technology, entrepreneurship, finance, legal, IP, and strategic consulting will support your startup right from the start.

Investment focus

Biotechnology, Medical, Software
Seed, Pre-Seed, Series A
Austria, Slovenia

Portfolio highlights

subdron — subdron focuses on data processing in underwater inspections and autonomous underwater navigation.
infrared.city — Infrared City is a platform for intelligent and resilient design powered by Artificial Intelligence. We make complex environmental simulations accessible and understandable for all stakeholders of the built environment. Our state-of-the-art machine learning models provide real-time feedback on the performance of design proposals and can guideclimate informed decisions at every step of the process. Infrared City currently provides feedback on solar, sunlight and wind performance. For more information, please visit www.infrared.city
VALANX Biotech — Protein conjugation. Specific, fast and cost effective.

APX Ventures offers digital solutions, including pay-per-click, custom web services, SEO, and cloud services.

Investment focus

Software, Artificial Intelligence, Information Technology
Seed, Series A, Pre-Seed
Germany, Austria, United Kingdom

Portfolio highlights

sewts — Founded in 2019 and based in Munich, sewts GmbH provides cutting-edge perception software, pushing the boundaries of robotics in processing of easily deformable materials. sewts has developed and demonstrated a unique technology that uses high-precision finite element method (FEM) simulations to efficiently train machine learning algorithms. Theintelligent software solution enables countless applications in industrial automation like the handling of textiles in industrial laundries or the manufacturing of garment. sewts is backed by APEX Ventures, Bayern Kapital, High-Tech Gründerfonds, UnternehmerTUM Initiative for Industrial Innovators and a couple of highly experienced business angels.
Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

Investing globally in technologies extending healthy lifespans

Investment focus

Biotechnology, Health Care, Personal Health
Seed, Convertible Note, Pre-Seed
United States, United Kingdom, The Netherlands

Portfolio highlights

Yuva Biosciences — Using cutting edge mitochondrial science to develop cosmeceuticals and pharmaceuticals.
MitoRx Therapeutics — Developing revolutionary mitochondrial-protective therapeutics which reverse mitochondrial dysfunction to arrest decline in muscular dystrophy and neurodegeneration. MitoRx Therapeutics' first-in-class first-in-target platform has potential to arrest the progression of some of the most challenging diseases.
Rejuvenation Technologies — Rejuvenation Technologies is a biotechnology company that developed nucleoside-modified TERT mRNA to safely and rapidly extend telomeres. The company is headquartered in Mountain View, California.

R42 Group is a venture fund and an institute which invents, invests and informs covering AI, deep science, 5G mobile, biotech and fintech.

Investment focus

Biotechnology, Health Care, Information Technology
Seed, Pre-Seed, Series A
United Kingdom, United States, Austria

Portfolio highlights

Senisca — Developing a new generation of senotherapeutic interventions to target the diseases and aesthetic signs of ageing.
KetoSwiss — KetoSwiss is a Swiss-based BioTech startup that strives to bring ketone bodies back into the modern world to combat diseases. It develops and clinically tests a novel nutraceutical/medical food for the dietary preventive therapy of higher-frequency migraines and possibly other related neurological diseases characterized by a metabolicdysfunction (such as Alzheimer's disease). KetoSwiss is headquartered at the Technologie Park Basel, in Basel Switzerland, where it is part of a dynamic scientific and entrepreneurial community composed of world-leading academic research laboratories, flourishing life sciences spin-offs and s world-leading biotech-startup-ecosystem.
Reservoir Neuroscience — Reservoir Neuroscience is a biopharma company that develops novel therapeutics to repair dysfunctional blood vessels in the brain. Reservoir Neuroscience was founded in 2019 and is based in Emeryville, California.

We deploy early stage capital to fuel the growth of need-driven health technology companies.

Investment focus

Health Care, Artificial Intelligence, Software
Seed, Pre-Seed, Series A
United States, United Kingdom, Austria

Portfolio highlights

Ryver — We provide software to generate synthetic medical images and assess their privacy as well as quality
CryoCloud — CryoCloud Accelerate your protein structure determination - Bring your cryo-EM data analysis to the next level by using our cloud-based image analysis workflow.
Zetta Genomics — Zetta Genomics unleashes the power of genomic data to improve health outcomes for millions of patients around the world - and realise the potential of

HCVC is an early-stage Venture Capital firm backing hardtech companies worldwide. Beyond its fund, HCVC supports hardtech founders through Hardware Club, a selective global community of 500+ startups with dedicated resources, partnerships and events.

Investment focus

Software, Artificial Intelligence, Hardware
Seed, Series A, Pre-Seed
United States, France, United Kingdom

Portfolio highlights

atmio — atmio helps natural gas operations to find, fix and report methane emissions easily.
Transmutex SA — Producing clean energy from nuclear waste is the challenge Transmutex is taking on. Based on experimentaly validated science from CERN in Geneva.
Chiral — Next-generation electronics with nanomaterials

Polaris Partners invests in healthcare and biotechnology companies. Their healthcare portfolio companies' care delivery models include digital health, consumer-centric businesses, patient-provider solutions, data science, and analytics. Their life sciences and biotechnology portfolio companies focus on molecules and platforms, therapeutics,and genomics.